Skip to content
healthcare.dev

Labetalol Hydrochloride

NDC 10135-713, Labetalol, tablet, film coated, from Marlex Pharmaceuticals Inc.

Product NDC
10135-713
Status
Listed
Labeler
Marlex Pharmaceuticals Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LABETALOL300 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
10135-713-0110135071301100 TABLET, FILM COATED in 1 BOTTLE (10135-713-01)
10135-713-0510135071305500 TABLET, FILM COATED in 1 BOTTLE (10135-713-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/28c91727-e5a8-48b3-a4df-d7bec8feda40

Use it

Look up 10135-713 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.